Avian and Swine Flu News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on the Avian and Swine Flu from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

In preparation for swine-flu vaccinations next month, Washington's Health Department ... temporarily suspended a rule that limits the amount of a mercury preservative [called Thimerosal] in vaccines given to pregnant women and children under the age of 3. Thimerosal has been eliminated from most vaccines in the United States, but it will be added to the bulk of the swine-flu vaccine. A vocal minority believes the compound could be linked to autism. About 15 percent of the vaccine supply will be mercury-free. Thimerosal will be added to the vaccine because it is being produced in vials that contain enough medication for 10 shots. The mercury compound kills bacteria, lowering the risk that the drug will be contaminated by needles used to withdraw separate doses. "Every time you introduce a needle, you run a risk of introducing a potential contaminant," said Dr. Tony Marfin, state epidemiologist for infectious disease. Mercury-free vaccine will be produced in single-dose vials. Nasal sprays do not contain mercury but are not recommended for children under the age of 2 and pregnant women, because they contain live, weakened virus. The law limiting the mercury preservative will be suspended for six months and applies only to the swine-flu vaccines. Once common in vaccines, thimerosal has been largely phased out in most wealthy nations. Children's vaccines in the United States are almost exclusively mercury-free, single-dose injections. After 1976's mass vaccination against a different swine-flu strain, about 500 people developed a neurological disorder called Guillain-Barre Syndrome (GBS), and some died. Scientists still haven't figured out why.

Note: To watch a vitally important 10-minute clip from CBS's 60 Minutes revealing government complicity in the deaths of 300 Americans and permanent paralysis of thousands more from the vaccine during the 1976 swine flu scare, click here. This is the most revealing clip by far on the swine flu that we've seen. For much more information on the dangers of thimerosal in vaccines, click here.

Healthy people who catch swine flu but show only mild symptoms should not be given Tamiflu, the World Health Organisation (WHO) has said. The advice contradicts British policy on the issue, which has seen hundreds of thousands of doses of the antiviral given to people with the virus. Today's advice, published on the WHO website, said most patients were experiencing typical flu symptoms and would get better within a week. It said Tamiflu (also called oseltamivir) and another antiviral Relenza (also called zanamivir) should not be given to healthy people who have only mild symptoms. The latest WHO advice, from a panel of international experts, comes as new figures show that 45,986 courses of antivirals were given to patients in England in the week ending August 18. In the previous week, 90,363 courses of antivirals were given out. There have been fears that mass use of Tamiflu will encourage the virus to become resistant to the antiviral. Researchers have also expressed concern over the side effects of the drug, including sickness, nightmares and insomnia in children. A team from Oxford University said earlier this month children with mild symptoms should not be given the antiviral to combat swine flu and urged the Department of Health to urgently rethink its policy.

Note: To read an article showing Tamiflu and Relenza may not be safe for children, click here. For other incisive articles revealing major manipulations involving the swine flu, click here.

In an interview with SPIEGEL, epidemiologist Tom Jefferson speaks about dangerous fear-mongering, misguided, money-driven research and why we should all be washing our hands a lot more often. SPIEGEL: Do you consider the swine flu to be particularly worrisome? Jefferson: There are some people who make predictions year after year, and they get worse and worse. None of them so far have come about, and these people are still there making these predictions. Sometimes you get the feeling that there is a whole industry almost waiting for a pandemic to occur. SPIEGEL: Who do you mean? Jefferson: The WHO and public health officials, virologists and the pharmaceutical companies. They've built this machine around the impending pandemic. And there's a lot of money involved, and influence, and careers, and entire institutions! And all it took was one of these influenza viruses to mutate to start the machine grinding. SPIEGEL: Do you think the WHO declared a pandemic prematurely? Jefferson: Don't you think there's something noteworthy about the fact that the WHO has changed its definition of pandemic? The old definition was a new virus, which went around quickly, for which you didn't have immunity, and which created a high morbidity and mortality rate. Now the last two have been dropped, and that's how swine flu has been categorized as a pandemic.

Note: For lots more on the Swine Flu "false pandemic," click here.

In February 1976, an outbreak of swine flu struck Fort Dix Army base in New Jersey, killing a 19-year-old private and infecting hundreds of soldiers. Concerned that the U.S. was on the verge of a devastating epidemic, President Gerald Ford ordered a nationwide vaccination program at a cost of $135 million (some $500 million in today's money). Within weeks, reports surfaced of people developing Guillain-Barré syndrome, a paralyzing nerve disease that can be caused by the vaccine. By April, more than 30 people had died of the condition. Facing protests, federal officials abruptly canceled the program on Dec. 16. The epidemic failed to materialize. Medical historians and epidemiologists say ... the decisions made in the wake of the '76 outbreak — and the public's response to them — provide a cautionary tale for public health officials, who may soon have to consider whether to institute draconian measures to combat the disease. "I think 1976 provides an example of how not to handle a flu outbreak," says Hugh Pennington, an emeritus professor of virology at Britain's University of Aberdeen. Despite modern advances in microbiology, today's health officials still make decisions in a "cloud of uncertainty," Pennington says. "At the moment, our understanding of the current outbreak is similarly limited. For example, we don't yet understand why people are dying in Mexico but not elsewhere." Howard Markel, director of the Center for the History of Medicine at the University of Michigan and a historical consultant to the CDC on flu pandemics, says the most vexing decision facing health officials is when to institute mass vaccination programs.

Note: To watch two short commercials made in 1976 showing clear scare tactics, click here. Then read about and watch a highly revealing 60 Minutes segment covering this deception. Only one person died from the actual flu in this 1976 "epidemic," yet more than 30 died of the flu vaccine. To explore the serious risks of vaccines reported in the media, click here. For lots more on bird and swine flu scares, click here.

Federal health authorities have signed a two-year deal to help states buy more than half a billion dollars worth of the antiviral drug Tamiflu as a hedge against a pandemic of deadly avian influenza, but there is a catch: States will have to pay for three-quarters of it. Under terms of the deal negotiated with Roche by the Department of Health and Human Services, the states can order up to 31 million packets of Tamiflu -- each containing a 10-pill course of treatment -- for a total cost of $596 million over the next two years. The Bush administration announced late Friday that it had contracted with Swiss drugmaker Roche Laboratories Inc. to supply Tamiflu for stockpiles in all 50 states. The federal government, meanwhile, plans to build its own centralized stockpile. The plan is to have enough antiviral drug in state and federal warehouses by December 2008 to treat 81 million people. Tamiflu is considered by scientists to be the first line of defense against the H5N1 strain of bird flu. The disease is currently confined primarily to chickens, ducks and some wild waterfowl, but researchers fear it could mutate into a form that spreads easily among humans.

Note: No mention is made here that Donald Rumsfeld has already made millions from sales of Tamiflu, and that he was on the board of the company that developed the drug. Many top researchers also believe there is little chance of avian flu mutating. Why are we spending hundreds of millions of dollars to combat a virus which has not even mutated yet? To verify these and other vital facts, see http://www.WantToKnow.info/avianflu

Just as President George W. Bush is launching an ambitious plan to guard against an avian flu pandemic, an administration program to prepare for a potential anthrax attack is running into new and unexpected hurdles. VaxGen Inc., a California biotech firm that last year was awarded an $877.5 million contract to supply a newly invented, and so far unlicensed, anthrax vaccine, acknowledged this week that it won't begin to start deliveries to the federal government until the latter part of next year -- six months later than it originally intended. For months, investigators on both sides of the aisle have expressed concerns that the administration may have invested too big a chunk of the nation's biodefenses in one obscure and relatively untested company. Last year's decision by HHS to award the contract to the little-known VaxGen is being scrutinized by at least two congressional committees. The company's product will have to pass more large-scale tests proving its safety and effectiveness on people before it is fully licensed by the Food and Drug Administration for use on humans, and company officials say they do not expect it to be fully licensed at least until 2007. A New York Times report last December noted that...the company had faced lawsuits filed by investors who claimed VaxGen misinformed them about an AIDS vaccine that the company had heavily promoted but which later failed to work.

Note: For more on how greed and corruption in the pharmaceutical industry affects your health and wallet, see our Health Information Center.

The existence of the influenza vaccine ... may give us a sense of false security when it comes to the possibility of a pandemic outbreak of influenza. In fact, the flu vaccine must be reformulated each year to keep pace with the newest variants of this fast-mutating virus. The recipe for making the flu vaccine is simple. Take the current year's variant of the influenza virus, throw it into a stew with a strain of virus that leads to rapid proliferation. Incorporate the fast-growing strain into its own genes and start replicating it. From there, it's an easy matter to take those plentiful viruses and attenuate them for a flu vaccine. But the scientists who must determine what virus will cause the next year's illness run a high chance of being wrong. Some observers have put the odds of success at no better than 50-50. Even when they are right, the vaccine lasts only as long as that year's strain. Experts thought they saw big-league trouble coming in February 1976, when a few cases of severe swine flu broke out among young military recruits in Fort Dix, N.J. One of them, Pvt. David Lewis, 19, died. Lewis and four others were shown to be infected with the same H1N1 influenza virus as was responsible for the 1918 pandemic. But the swine-flu pandemic never materialized. In retrospect, some critics now say 40 million Americans were vaccinated for nothing. In fact, the only real illness to result from the swine flu adventure was caused by the vaccine: about one thousand people developed Guillain-Barre syndrome, a serious paralytic disease that could be traced directly to an immunological response to the inoculation.

Note: This article also discusses how new, intensified farming techniques for chickens, pigs, and ducks are the prime breeding ground for viruses which spread around the world. A powerful CBS 60 Minutes clip on the 1976 swine flu scare is available here. The intrepid 60 Minutes team shows how greed and blatant corruption led to the death of hundreds and paralysis of thousands as a direct result of the vaccine developed that year, while only one person died from the flu. For lots more, click here.

Vice-premier Sun Chunlan, one of the most senior government officials to visit the centre of the coronavirus outbreak [was] heckled by residents who yelled “fake, fake, everything is fake” as she inspected the work of a neighbourhood committee charged with taking care of quarantined residents. Videos posted online showed Sun and a delegation walking along the grounds while residents appeared to shout from their apartment windows, “fake, fake,” “it’s all fake,” as well as “we protest”. Since 12 February, all residential compounds in Wuhan have been put under lockdown, barring most residents from leaving their homes. In an unusual turn of events, on Friday various Chinese state media outlets reported the videos showing public discontent. Such videos are frequently censored. Yet, the People’s Daily posted a video subtitled in English showing one person shouting “fake, fake,” which has since been removed. A government-affiliated account on WeChat ... said in an essay posted on Thursday that all the facts of the incident were “basically true”. According to state broadcaster CCTV, Sun held a meeting immediately after the incident to deal with the complaints. Staff have been dispatched to visit the residents one by one. Observers say state media may be trying to co-opt discussion of the videos, which circulated widely online, and provide their own narrative of events. Elsewhere in China, schools in provinces reporting no new cases for a number of days, started to set their opening dates in a sign of the country returning to normal. Wuhan reported 126 new coronavirus cases on Thursday but the wider province of Hubei excluding the capital recorded none for the first time during the outbreak.

Note: Remember all of the privacy and freedoms given up after 9/11? How many of those have been given back? Learn more about the serious risk of the Coronavirus increasing the surveillance state in this excellent article. For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the disappearance of privacy from reliable major media sources.

Scientists agreed not to publish certain details of research showing how lethal bird flu can be made contagious after a U.S. biosecurity panel asked that it be kept secret for security reasons. The study at Erasmus Medical Center in Rotterdam described the genetic changes needed to make the H5N1 avian influenza strain spread easily among ferrets and potentially people. The research is under review for publication in the journal Science. It was commissioned by the U.S. National Institutes of Health, the center said yesterday in a statement on its website. Knowing the genetic sequence of a deadly, infectious strain may enable the virus to be recreated through reverse engineering. The censorship was requested by the National Science Advisory Board for Biosecurity, which was created in the aftermath of the 2001 anthrax attacks and advises the U.S. Department of Health and Human Services. The panel called for certain data to be kept secret after determining that the risks of publishing it outweigh the benefits, the Erasmus Medical Center said. “The researchers have reservations about this recommendation but will observe it,” the center said in the statement.

Note: For key major media reports revealing manipulation around both the avian and swine flus, click here. For solid evidence that Lyme disease originated in a secret government germ laboratory, click here.

Attempts to censor details of controversial influenza experiments that created a highly infectious form of bird-flu virus are unlikely to stop the information from leaking out, according to scientists familiar with the research. The US Government has asked the editors of two scientific journals to refrain from publishing key parts of research on the H5N1 strain of bird-flu in order to prevent the information falling into the hands of terrorists intent on recreating the same flu strain for use as a bioweapon. However, scientists yesterday condemned the move. Some said that the decision comes too late because the information has already been shared widely among flu researchers, while others argued that the move could obstruct attempts to find new vaccines and drugs against an infectious form of human H5N1 if it appeared naturally. Professor Richard Ebright, a molecular biologist at Rutgers University in Piscataway, New Jersey, said that the research, which was funded by the US Government, should never have been done without first assessing the risks and benefits. The work posed risks that outweighed benefits and that were clearly foreseeable before the work was performed, Professor Ebright said. The work should have been reviewed at the national or international level before being performed, and should have been restricted at a national or international level before being performed, he said.

Note: For key major media reports revealing manipulation around both the avian and swine flus, click here. For solid evidence that Lyme disease originated in a secret government germ laboratory, click here.

A leading health expert says the swine flu scare was a "false pandemic" led by drugs companies that stood to make billions from vaccines. Wolfgang Wodarg, head of health at the Council of Europe, claims major [drug] firms organised a "campaign of panic" to put pressure on the World Health Organisation to declare a pandemic. He believes it is "one of the greatest medicine scandals of the century" — and has called for an inquiry. Dr Wodarg said: "It's just a normal kind of flu. It does not cause a tenth of deaths caused by the classic seasonal flu. The great campaign of panic we have seen provided a golden opportunity for representatives from labs who knew they would hit the jackpot in the case of a pandemic being declared. We want to clarify everything that brought about this massive operation of disinformation. We want to know who made decisions, on the basis of what evidence, and precisely how the influence of the pharmaceutical industry came to bear on the decision-making." He added: "A group of people in the WHO is associated very closely with the pharmaceutical industry."

Note: For powerfully revealing reports of the corruption regarding swine flu and previous health scares, click here.

A new analysis, using H1N1 deaths in the United States in the spring and projecting likely outcomes for this fall, shows that a typical -- or possibly even a milder flu season than average -- should have been expected. The finding [raises] the question: Has swine flu been oversold? The new study, done by researchers at Harvard University and the Medical Research Council Biostatistics Unit in the U.K., says swine flu cases in the spring indicated a flu season that might be, at worst, slightly worse than normal. "It would have been great to have that back in June," said Philip Alcabes, an associate professor in the program in urban public health at Hunter College's School of Health Sciences. "There would have been one more bit of evidence behind my assertion six months ago" that people were overreacting to H1N1. Around the time that swine flu first started making headlines, Alcabes' book, Dread: How Fear and Fantasy Have Fueled Epidemics From the Black Death to Avian Flu, was published, and he said the circumstances surrounding H1N1 provide an apt case study. "I think that it was, from the very beginning, created as a crisis and overstated as a real threat," he said.

Note: For powerful, reliable articles showing major profiteering and fear-mongering around the swine flu to the great risk of public health, click here and here.

Swiss drugmaker Novartis said sales would grow faster than expected this year, even without a shot in the arm of up to $700 million from its H1N1 swine flu pandemic vaccine. Third-quarter net profit at Novartis ... nudged up 1 percent to $2.1 billion. This year is turning out to be better than initially feared for Novartis and other major pharmaceutical companies, thanks to hefty price increases and windfall sales arising from the H1N1 outbreak. Both Pfizer, the world's biggest drugmaker, and Eli Lilly topped earnings forecasts this week. Roche reported a sharp jump in sales of its Tamiflu drug for flu last week and analysts expect GlaxoSmithKline's Relenza will also see strong sales in the third quarter. On the vaccine front, Glaxo, Sanofi-Aventis and AstraZeneca are all expected to highlight an expected jump in fourth-quarter sales due to swine flu. The H1N1 flu vaccine is expected to contribute about $400-700 million of sales in the fourth quarter.

Note: Donald Rumsfeld personally made millions as a direct result of the avian flu scare a few year ago. For more on this, click here. For more on pharmaceutical corporation profiteering from swine flu vaccines, click here.

U.S. military troops will begin getting required swine flu shots in the next week to 10 days, with active duty forces deploying to war zones and other critical areas going to the front of the vaccine line. Air Force Gen. Gene Renuart also [said] that as many as 400 troops are ready to go to five regional headquarters around the country to assist federal health and emergency management officials. The Pentagon has bought 2.7 million vaccines, and 1.4 million of those will go to active duty military. National Guard troops on active duty are also required to receive the vaccine, as are civilian Defense Department employees who are in critical jobs. "Because I can compel people to get the shots, larger numbers will have the vaccine," said Renuart, commander of U.S. Northern Command. "They will, as a percentage of the population, be vaccinated more rapidly than many of us. So we may see some objective results, good or not, of the vaccinations." Shots will be doled out on a priority basis, with troops preparing to deploy first, followed by other active duty forces, particularly any who might be needed to quickly respond to a hurricane or other emergency. Inoculating the military is a key requirement of the Pentagon's emergency plan, as a way to ensure that troops are available to protect the nation. They also will be on tap to provide help to states if problems come up as the flu season continues.

Note: It is not made clear by this article precisely how military personnel will "assist" civilian authorities handle a mass swine flue vaccination program. The plans to use the military for this purpose are unprecedented and formerly illegal. For lots more from reliable sources on the dangers of vaccines, click here and here.

The nation's political crosscurrents appear to have created vaccine skeptics of many stripes. Many citizens are less inclined than ever to accept the warnings of the Department of Health and Human Services or the recommendations of its Centers for Disease Control and Prevention, says Sandra Quinn, a University of Pittsburgh public health professor who has just completed a national survey of attitudes about the flu vaccine. Vaccine refusers have long decried vaccine mandates and campaigns as an unwarranted intrusion of parents' and local school boards' rights. For a new generation of vaccine skeptics, there are new objects of distrust. For some, it flows from a suspicion of the multinational corporations that develop and manufacture vaccines. For others, it comes from a belief that media outlets have hyped the pandemic flu story to secure the attention of readers and the revenue of advertisers. And many simply doubt the competency and independence of government agencies, which they believe are too inept, overwhelmed or co-opted by corporate interests to secure the safety of the nation's drugs and food supply. Adding to the wariness toward the forthcoming H1N1 vaccine is the fact that the formulations used on patients in the United States might require the use of adjuvants -- special agents added to a vaccine mix that rev up the immune system and foster a stronger immune response. While adjuvants have been used in vaccines in Europe for many years, the FDA has never approved them for widespread use in the United States. Some vaccine critics in Great Britain have charged that one adjuvant used in European formulations -- squalene -- is associated with a wide range of vague but persistent symptoms.

Note: Adjuvants are being added to vaccines, yet the resulting combined formula is not being tested for safety; the individual components are tested separately. The process for the testing of vaccines is endangering our health. For lots more on the dangers of vaccines and squalene in particular, read respected Dr. Joseph Mercola's incisive article available here.

U.S. government health officials are urging Americans not to panic over estimates that up to 90,000 people might die in the United States from swine flu this year. "Everything we've seen in the U.S. and everything we've seen around the world suggests we won't see that kind of number if the virus doesn't change," said Dr. Thomas Frieden, head of the Centers for Disease Control and Prevention. While the swine flu seems quite easy to catch, it so far hasn't been more deadly than the flu strains seen every fall and winter — many people have only mild illness. And close genetic tracking of the new virus as it circled the globe over the last five months so far has shown no sign that it's mutating to become more virulent. Still, the CDC has been preparing for a worst-case flu season as a precaution — in July working from an estimate slightly more grim than one that made headlines this week — to make sure that if the virus suddenly worsened or vaccination plans fell through, health authorities would know how to react. On Monday the White House released a report from a group of presidential advisers that included a scenario where anywhere from 30 percent to half of the population could catch what doctors call the "2009 H1N1" flu, and death possibilities ranged from 30,000 to 90,000. "We don't think that's the most likely scenario," CDC flu specialist Dr. Anne Schuchat said of the presidential advisers' high-end tally. In a regular flu season, up to 20 per cent of the population is infected and 36,000 die.

Note: Like the avian flu several years ago, the swine flu is turning out to be largely fear-mongering which has poured billions of dollars into the deep pockets of the medical/industrial complex. For lots more reliable information from major media reports on this, click here.

Many GPs, as well as their patients, may be reluctant to be immunised against swine flu once a vaccine is developed, surveys suggest today. A survey of GPs published on Healthcare Republic, the website of GP magazine, found that up to 60% of GPs may decline vaccination. Although the numbers who responded were small – 216 GPs – they are in line with a much bigger survey of nurses published a week ago by Nursing Times, which found that a third of 1,500 nurses would refuse vaccination. A Canadian study published today in the journal Emerging Health Threats suggests the public, too, will have reservations that must be overcome if a vaccination campaign is to be successful in the autumn or winter. The study, which used focus groups to establish the likely response of different people to a vaccine, pointed to the need to win over people who believe that alternative therapies and a good diet are a better option than vaccines. But the biggest problem in persuading people and healthcare professionals to have the jab may be the relative shortage of evidence from trials about its safety and efficacy. Because of the urgent need for a vaccine, testing will be limited. Among the GPs who responded to the survey published by Healthcare Republic, 29% said they would not choose to have the vaccine and 29% said they were unsure whether or not they would. The biggest reason given by those who said they would not have it was concern that the safety trials would not be adequate: 71.3% said they were "concerned that the vaccine has not yet been through sufficient trials to guarantee safety". Half – 50.4% – said they "believe that swine flu is too mild to justify taking the vaccine".

Note: Yet the Massachusetts Senate has now passed a bill which would impose fines up to $1,000 and jail up to 30 days for those who refuse vaccines or quarantine orders in a health emergency. Other states are considering similar legislation. For lots more on the real dangers of the swine flu vaccine, click here.

The flu drugs Tamiflu and Relenza may not be worthwhile to treat seasonal influenza in healthy adults, British researchers reported on Friday. "Recommending the use of antiviral drugs for the treatment of people presenting with symptoms is unlikely to be the most appropriate course of action," wrote Jane Burch of the University of York and colleagues. Their study, published in the Lancet Infectious Diseases, supports an advisory from the World Health Organization that says healthy patients who get H1N1 swine flu without suffering complications do not need to be treated with antivirals. Burch's team reviewed many different published studies on Tamiflu and Relenza. "We present the results for healthy adults and people at-risk of influenza-related complications," they wrote. Both drugs shaved about half a day, on average, off the time patients were ill, they found. Influenza usually affects people for about a week. The drugs worked a little better in people who have a high risk of complications, such as patients with diabetes or asthma, with Relenza cutting sickness by almost a day and Tamiflu by three-quarters of a day, on average. This suggests the drugs should be reserved for people who need them the most, the researchers concluded.

Note: To read a powerful account of the real dangers of the swine flu scare, click here.

A warning that the new swine flu jab is linked to a deadly nerve disease has been sent by the Government to senior neurologists in a confidential letter. The letter from the Health Protection Agency, the official body that oversees public health, has been leaked to The Mail on Sunday, leading to demands to know why the information has not been given to the public before the vaccination of millions of people, including children, begins. [The letter] tells the neurologists that they must be alert for an increase in a brain disorder called Guillain-Barre Syndrome (GBS), which could be triggered by the vaccine. GBS attacks the lining of the nerves, causing paralysis and inability to breathe, and can be fatal. The letter, sent to about 600 neurologists on July 29, is the first sign that there is concern at the highest levels that the vaccine itself could cause serious complications. It refers to the use of a similar swine flu vaccine in the United States in 1976 when: * More people died from the vaccination than from swine flu. * 500 cases of GBS were detected. * The vaccine may have increased the risk of contracting GBS by eight times. * The vaccine was withdrawn after just ten weeks when the link with GBS became clear. * The US Government was forced to pay out millions of dollars to those affected. Concerns have already been raised that the new vaccine has not been sufficiently tested and that the effects, especially on children, are unknown. The British Neurological Surveillance Unit (BNSU), part of the British Association of Neurologists, has been asked to monitor closely any cases of GBS as the vaccine is rolled out. One senior neurologist said last night: ‘I would not have the swine flu jab because of the GBS risk.’

Note: For more on the swine flu scare and the dangers of vaccines, click here.

A complicated list of who should get [swine] flu vaccine in the fall is now set. When the vaccine starts arriving in September, first in line will be pregnant women; the caretakers of infants; children and young adults; older people with chronic illness; and health-care workers. That's the advice of a 15-member committee of experts, which met all day Wednesday at the Centers for Disease Control and Prevention in Atlanta to advise the federal government on vaccine policy. The priority list names targeted groups and suggests the order in which they should be vaccinated. "The results of this meeting will kick planning into high gear," said Pascale Wortley of the CDC's Immunization Services Division. "This is a watershed moment." All that's missing is the vaccine, knowledge of how well it works and the nitty-gritty details of how to deliver it to people's arms and noses. The vaccine will come in two forms: the traditional flu shot and a "live" vaccine squirted into the nose that contains a weakened version of the new virus. Some of the vaccine will be stored in multi-dose vials containing thimerosal, an antibacterial additive that contains mercury. But there will also be single-dose syringes without thimerosal, a substance that some assert is harmful to children. Among the many unanswered questions is whether two doses will be necessary to provide full protection, how close in time two shots can be given and how big the dose will be. Vaccination programs may start before the answers are known.

Note: Why is thimerosal being used? It is a mercury additive around which there appears to be a major cover-up. For several other revealing articles which suggest an dangerous agenda with the swine flu vaccine, click here.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.